Certified by Founder Lodge
Clarke Capital Partners
United States - Provo
INVESTOR
1 Disclosed Funding Rounds $10,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Private Investment Firm Focused on Alternative Assets Classses, including Growing Companies normally producing $1-$5 MM of EBITDA with Solid Management Teams and Defensible Business Strategie
| Company | Date | Round | Raised |
|---|---|---|---|
 Biolexis Therapeutics, Inc. |
November, 30 ,2023 | Series A | $10,000,000 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
Numeral(US) | $18,000,000 | (Mar 7, 2025)
ctrl+s GmbH | $1,083,350 | (Mar 7, 2025)
hema.to GmbH | $3,900,060 | (Mar 7, 2025)
Lumata Health | $20,000,000 | (Mar 7, 2025)
Uniti AI | $4,000,000 | (Mar 7, 2025)
